Pharmaceutical Processing Seals Global Market to Reach $2.79 Billion by 2026

The “Pharmaceutical Processing Seals Global Market Report 2022, By Type, Material, Application” report has been added to ResearchAndMarkets.com’s offering.

The global pharmaceutical processing seals market is expected to grow from $1.80 billion in 2021 to $2.03 billion in 2022 at a compound annual growth rate (CAGR) of 12.4%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $2.79 billion in 2026 at a CAGR of 8.3%.

The main types of pharmaceutical processing seals are O-rings, gaskets, lip seals, D seals, and others. O-ring seals are used to prevent leaks from pumps, valves, cylinders, and connectors used in pharmaceutical processing. The different materials include metals, PTFE, silicone, nitrile rubber, EPDM, others and are used in various applications such as manufacturing equipment, agitators, mixers, reactors, gear boxes, and others.

North America was the largest region in the pharmaceutical processing seals market in 2021. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The rise in chronic diseases is significantly contributing to the growth of the pharmaceutical processing seals market. Chronic diseases are defined as conditions that last more than a year and require ongoing medical care; they are global, national health issues that involve mortality and morbidity. These include heart disease, cancer, and diabetes.

The rise in chronic diseases is driving up demand for pharmaceuticals, which in turn is driving up demand for pharmaceutical processing seals. For instance, according to the International Diabetes Federation, in 2021, 537 million adults are suffering from diabetes worldwide, which is a huge increase as compared to 463 million adults living with diabetes in 2019.

Technological advancements are shaping the pharmaceutical processing seals market. Major companies operating in the pharmaceutical processing seals sector are focused on developing new technological solutions to meet consumer demand and strengthen their position.

For instance, in November 2021, Crawford Packaging, a UK-based packaging machines company launched Evolution S, the top seal packaging technology machinery with advanced tray sealing solution manufactured by Packaging Automation Ltd. Evolution S – Packing Automation has developed the world’s most efficient tray sealing technology, raising the bar for precision and fast sealing rates while decreasing the packaging area’s necessary footprint in a single lane configuration.

Markets Covered:

  1. By Type: O-rings; Gaskets; Lip seals; D seals; Others (Diaphragms and X-rings)
  2. By Material: Metals; PTFE; Silicone; Nitrile Rubber; EPDM; Others
  3. By Application: Manufacturing Equipment; Agitators; Mixers; Reactors; Gear Boxes; Others

Key Topics Covered:

1. Executive Summary

2. Pharmaceutical Processing Seals Market Characteristics

3. Pharmaceutical Processing Seals Market Trends And Strategies

4. Impact Of COVID-19 On Pharmaceutical Processing Seals

5. Pharmaceutical Processing Seals Market Size And Growth

6. Pharmaceutical Processing Seals Market Segmentation

7. Pharmaceutical Processing Seals Market Regional And Country Analysis

8. Asia-Pacific Pharmaceutical Processing Seals Market

9. China Pharmaceutical Processing Seals Market

10. India Pharmaceutical Processing Seals Market

11. Japan Pharmaceutical Processing Seals Market

12. Australia Pharmaceutical Processing Seals Market

13. Indonesia Pharmaceutical Processing Seals Market

14. South Korea Pharmaceutical Processing Seals Market

15. Western Europe Pharmaceutical Processing Seals Market

16. UK Pharmaceutical Processing Seals Market

17. Germany Pharmaceutical Processing Seals Market

18. France Pharmaceutical Processing Seals Market

19. Eastern Europe Pharmaceutical Processing Seals Market

20. Russia Pharmaceutical Processing Seals Market

21. North America Pharmaceutical Processing Seals Market

22. USA Pharmaceutical Processing Seals Market

23. South America Pharmaceutical Processing Seals Market

24. Brazil Pharmaceutical Processing Seals Market

25. Middle East Pharmaceutical Processing Seals Market

26. Africa Pharmaceutical Processing Seals Market

27. Pharmaceutical Processing Seals Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The Pharmaceutical Processing Seals Market

29. Pharmaceutical Processing Seals Market Future Outlook and Potential Analysis

30. Appendix

Companies Mentioned

  • Trelleborg AB
  • Freudenberg Group
  • Flowserve Corporation
  • James Walker & Co.
  • Parker-Hannifin Corporation
  • Saint-Gobain S.A.
  • Garlock Sealing Technologies
  • John Crane
  • IDEX Corporation
  • Marco Rubber and Plastics
  • Technetics Group
  • Sealmatic
  • Maffs Seals Pvt. Ltd.
  • Quantech Sealing Systems
  • EagleBurgmann India Pvt. Ltd.

For more information about this report visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version